Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In Silico Studies on Zinc Oxide Based Nanostructured Oil Carriers with Seed Extracts of Nigella sativa and Pimpinella anisum as Potential Inhibitors of 3CL Protease of SARS-CoV-2. | Molecules | 2022 | 35807545 | PubTator, text mining | PubMed |
| The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2. | Molecules | 2022 | 35807457 | PubTator, text mining | PubMed |
| Heat Shock Alters the Proteomic Profile of Equine Mesenchymal Stem Cells. | Int J Mol Sci | 2022 | 35806237 | PubTator, text mining | PubMed |
| Porcine reproductive and respiratory syndrome virus non-structural protein 4 cleaves guanylate-binding protein 1 via its cysteine proteinase activity to antagonize GBP1 antiviral effect. | Vet Res | 2022 | 35804432 | PubTator, text mining | PubMed |
| The role of multi-omics in the diagnosis of COVID-19 and the prediction of new therapeutic targets. | Virulence | 2022 | 35801633 | PubTator, text mining | PubMed |
| SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants. | Clin Exp Vaccine Res | 2022 | 35799876 | PubTator, text mining | PubMed |
| Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2. | Antiviral Res | 2022 | 35798223 | PubTator, text mining | PubMed |
| MiR-142-5p/FAM134B Axis Manipulates ER-Phagy to Control PRRSV Replication. | Front Immunol | 2022 | 35795666 | PubTator, text mining | PubMed |
| Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection. | J Infect | 2022 | 35793758 | PubTator, text mining | PubMed |
| From Prevention to Therapy: A Roadmap of Nanotechnologies to Stay Ahead of Future Pandemics. | ACS Nano | 2022 | 35793456 | PubTator, text mining | PubMed |
| Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review. | J Genet Eng Biotechnol | 2022 | 35792966 | PubTator, text mining | PubMed |
| An outlook on potential protein targets of COVID-19 as a druggable site. | Mol Biol Rep | 2022 | 35790657 | PubTator, text mining | PubMed |
| Functional mutations of SARS-CoV-2: implications to viral transmission, pathogenicity and immune escape. | Chin Med J (Engl) | 2022 | 35788093 | PubTator, text mining | PubMed |
| A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals. | Eur J Med Chem | 2022 | 35779291 | PubTator, text mining | PubMed |
| Understanding the epigenetic mechanisms in SARS CoV-2 infection and potential therapeutic approaches. | Virus Res | 2022 | 35777502 | PubTator, text mining | PubMed |
| Correction: Exostosin glycosyltransferase 1 reduces porcine reproductive and respiratory syndrome virus infection through proteasomal degradation of nsp3 and nsp5. | J Biol Chem | 2022 | 35777197 | PubTator, text mining | PubMed |
| STAT and Janus kinase targeting by human herpesvirus 8 interferon regulatory factor in the suppression of type-I interferon signaling. | PLoS Pathog | 2022 | 35776779 | PubTator, text mining | PubMed |
| Interferon induction, evasion, and paradoxical roles during SARS-CoV-2 infection. | Immunol Rev | 2022 | 35775361 | PubTator, text mining | PubMed |
| Coronaviruses in wild animals sampled in and around Wuhan at the beginning of COVID-19 emergence. | Virus Evol | 2022 | 35769892 | PubTator, text mining | PubMed |
| Enteric viruses replicate in salivary glands and infect through saliva. | Nature | 2022 | 35768512 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=47